Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Funauchi

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Molecular and Clinical Oncology|December 7, 2020
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment lineKenji Nakano, Keiko Hayakawa, Yuki Funauchi, et al.
Cureus|January 21, 2025
Gemcitabine-Based Chemotherapy for Advanced Soft Tissue Sarcoma: Identifying the Appropriate Dose and ScheduleKenji Nakano, Naomi Hayashi, Xiofei Wang, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue SarcomaYasuyoshi Sato, Kenji Nakano, Kuniki Kawaguchi, et al.
Cancers|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue SarcomaYasuyoshi Sato, Kenji Nakano, Xiaofei Wang, et al.
Japanese Journal of Clinical Oncology|November 5, 2024
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS)Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2022
Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Satoshi Takagi, Takao Ukaji, et al.
Genes, Chromosomes & Cancer|January 1, 2019
Frequent mutations of genes encoding vacuolar H<sup>+</sup> -ATPase components in granular cell tumorsMasaya Sekimizu, Akihiko Yoshida, Sachiyo Mitani, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular and Clinical Oncology|December 7, 2020
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment lineKenji Nakano, Keiko Hayakawa, Yuki Funauchi, et al.
Cureus|January 21, 2025
Gemcitabine-Based Chemotherapy for Advanced Soft Tissue Sarcoma: Identifying the Appropriate Dose and ScheduleKenji Nakano, Naomi Hayashi, Xiofei Wang, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue SarcomaYasuyoshi Sato, Kenji Nakano, Kuniki Kawaguchi, et al.
Cancers|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue SarcomaYasuyoshi Sato, Kenji Nakano, Xiaofei Wang, et al.
Japanese Journal of Clinical Oncology|November 5, 2024
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS)Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2022
Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Satoshi Takagi, Takao Ukaji, et al.
Genes, Chromosomes & Cancer|January 1, 2019
Frequent mutations of genes encoding vacuolar H<sup>+</sup> -ATPase components in granular cell tumorsMasaya Sekimizu, Akihiko Yoshida, Sachiyo Mitani, et al.
Pageof 4